CNTA

12.30

0.73% -0.09

Handel nachbörslich: 12.54 0.24 +1.95%

Centessa Pharmaceuticals Plc Adr (CNTA)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$12.39

Offen:

$12.33

24-Stunden-Volumen:

509.88K

Relative Volume:

0.53

Marktkapitalisierung:

$1.81B

Einnahmen:

Nettoeinkommen (Verlust:

$-151.09M

KGV:

-7.8846

EPS:

-1.56

Netto-Cashflow:

$-160.51M

1W Leistung:

-9.63%

1M Leistung:

+4.59%

6M Leistung:

-25.45%

1J Leistung:

+28.80%

1-Tages-Spanne:

$12.09

$12.85

1-Wochen-Bereich:

$11.82

$13.84

52-Wochen-Spanne:

$7.75

$19.09

Centessa Pharmaceuticals Plc Adr Stock (CNTA) Company Profile

Firmenname

Centessa Pharmaceuticals Plc Adr

Sektor

Healthcare (1153)

Branche

Biotechnology (676)

Telefon

44 7391 789784

Adresse

3RD FLOOR, ALTRINCHAM, CHESHIRE

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

CNTA's Discussions on Twitter

Vergleichen Sie CNTA mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
CNTA Centessa Pharmaceuticals Plc Adr	12.30	1.81B	0	-151.09M	-160.51M	-1.56
VRTX Vertex Pharmaceuticals Inc	424.99	128.84B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	527.78	65.38B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	549.65	39.67B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.15	33.82B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	231.99	27.60B	3.81B	-644.79M	-669.77M	-6.24

Centessa Pharmaceuticals Plc Adr Stock (CNTA) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-05-08	Eingeleitet	Chardan Capital Markets	Buy
2025-03-31	Eingeleitet	Piper Sandler	Overweight
2025-01-07	Eingeleitet	TD Cowen	Buy
2024-09-20	Hochstufung	Morgan Stanley	Equal-Weight → Overweight
2024-09-19	Eingeleitet	B. Riley Securities	Buy
2024-07-18	Eingeleitet	Oppenheimer	Outperform
2023-11-15	Hochstufung	Jefferies	Hold → Buy
2023-10-26	Hochstufung	Morgan Stanley	Underweight → Equal-Weight
2023-06-21	Eingeleitet	Evercore ISI	Outperform
2023-06-12	Eingeleitet	Guggenheim	Buy
2023-03-17	Eingeleitet	SVB Securities	Outperform
2022-08-12	Herabstufung	Morgan Stanley	Overweight → Underweight
2022-06-17	Eingeleitet	BMO Capital Markets	Outperform
2022-06-03	Herabstufung	Jefferies	Buy → Hold
2022-02-11	Eingeleitet	Goldman	Neutral

Alle ansehen

Centessa Pharmaceuticals Plc Adr Aktie (CNTA) Neueste Nachrichten

May 10, 2025

Is Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) A Suitable Stock For New Investors Today? - Stocksregister

May 10, 2025

May 07, 2025

Ratios in Focus: Analyzing Centessa Pharmaceuticals plc ADR (CNTA)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX

May 07, 2025

May 02, 2025

Investor’s Delight: Centessa Pharmaceuticals plc ADR (CNTA) Closes Weak at 13.50, Down -1.53 - DWinneX

May 02, 2025

May 01, 2025

Was Centessa Pharmaceuticals plc ADR (CNTA)’s session last reading good? - uspostnews.com

May 01, 2025

Apr 24, 2025

Top investors say Centessa Pharmaceuticals plc ADR (CNTA) ticks everything they need - Sete News

Apr 24, 2025

Investor’s Toolkit: Key Ratios for Assessing MSCI Inc (MSCI)’s Performance - DWinneX

Apr 24, 2025

Financial Metrics Check: Centessa Pharmaceuticals plc ADR (CNTA)’s Ratios for Trailing Twelve Months - DWinneX

Apr 24, 2025

Apr 23, 2025

Should investors be concerned about Centessa Pharmaceuticals plc ADR (CNTA)? - uspostnews.com

Apr 23, 2025

Apr 10, 2025

Parsons Corp (PSN) Shares Up Despite Recent Market Volatility - News Heater

Apr 10, 2025

Apr 01, 2025

Lantheus Holdings Inc [LNTH] Insider Activity: An Update for Investors - knoxdaily.com

Apr 01, 2025

Mar 31, 2025

Piper Sandler Initiates Centessa Pharmaceuticals at Overweight With $38 Price Target - MarketScreener

Mar 31, 2025

Mar 26, 2025

Centessa Pharmaceuticals chief business officer sells $163,386 in stock - Investing.com

Mar 26, 2025

Mar 21, 2025

Centessa Pharmaceuticals CEO sells shares worth $918,060 By Investing.com - Investing.com South Africa

Mar 21, 2025

Centessa Pharmaceuticals CEO sells shares worth $918,060 - Investing.com India

Mar 21, 2025

Mar 19, 2025

Centessa Pharmaceuticals CAO sells shares worth $120,205 By Investing.com - Investing.com South Africa

Mar 19, 2025

Centessa Pharmaceuticals CAO sells shares worth $120,205 - Investing.com India

Mar 19, 2025

Centessa Pharmaceuticals’ general counsel sells $98,697 in stock - Investing.com

Mar 19, 2025

Mar 03, 2025

Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA)’s Stock Boosts 3.25%, But It May Be A Worthy Investment - Stocks Register

Mar 03, 2025

Feb 25, 2025

Ratios Revealed: Decoding Centessa Pharmaceuticals plc ADR (CNTA)’s Financial Health - The Dwinnex

Feb 25, 2025

Feb 18, 2025

Hemophilia Market Insights: Key Trends and Developments Across Different Types of Hemophilia | DelveInsight - GlobeNewswire Inc.

Feb 18, 2025

Feb 11, 2025

Centessa Pharmaceuticals officer sells shares worth $588,943 - Investing.com India

Feb 11, 2025

Feb 10, 2025

Aegon Ltd (AEG) looking to reclaim success with recent performance - SETE News

Feb 10, 2025

Adversity is less terrifying than hope: Wayfair Inc (W) - SETE News

Feb 10, 2025

Perhaps timely catching Autolus Therapeutics plc ADR (AUTL) would be a good idea - SETE News

Feb 10, 2025

Taking the lead: Centessa Pharmaceuticals plc ADR (CNTA) - SETE News

Feb 10, 2025

Feb 07, 2025